⌘K

Login Start Free

Home/Filings/4/0001193125-25-286134

4//SEC Filing

Fox Christine 4

Accession 0001193125-25-286134

CIK 0000818686other

View on SEC.gov Company Profile

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:01 PM ET

Size

4.8 KB

Accession

0001193125-25-286134

Insider Transaction Report

Form 4

Period: 2025-11-14

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

EVP, Head of U.S. Commercial

Transactions

Sale
Ordinary Shares
2025-11-14$25.11/sh−30,000$753,321→ 28,384 total

Footnotes (1)

[F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1

filerCIK 0001998173

Filing Metadata

Form type: 4
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 4:01 PM ET
Size: 4.8 KB

View on SEC.gov